Base4 Innovation

Base4 Innovation is a private UK biotechnology company developing single-molecule DNA sequencing technology and related genomics analysis tools. Historically, the company focused on a microdroplet-based long-read sequencing method designed to read single DNA molecules without initial amplification and to detect epigenetic marks such as methylated cytosine and methylated adenine directly. Publicly available materials describe Base4 as active and based in Cambridge, with work spanning high-throughput DNA sequencing, single-molecule analysis, and enabling technologies for healthcare and life sciences. Evidence also suggests the company has evolved its public-facing presence over time, and the currently accessible base4.co.uk site appears more informational than product-commercial, so recent pipeline and commercialization details are limited. Overall, Base4 should be viewed primarily as a platform and tools company rather than a therapeutics developer.